Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Aug 11, 2005
Financial News
Avontec raises EUR 14.5 million
...and DVC Deutsche Venture Capital. New investors BioMedinvest and KfW joined InnovationsKapital; UBG Goettingen-Hildesheim; and
Mediport
...
Read More
BioCentury
|
Feb 23, 2004
Emerging Company Profile
Corporate Profile
...employees: 8 Funds raised: E5.5 million ($6.4 million) Investors: DVC Deutsche Venture Capital; Innovations-Capital Goettingen;
Mediport
...
Read More
BioCentury
|
Jan 12, 2004
Emerging Company Profile
Corporate Profile
...Charité, and Medical Shool Hannover Employees: 26 Funds raised: $4.7 million Investors: Encysive Pharmaceuticals Inc.;
Mediport
...
Read More
BioCentury
|
Aug 1, 2000
Financial News
Texas Biotech funds Berlin subsidiary
...owned subsidiary, Revotar Biopharmaceuticals, raised DM10 million ($4.7 million) through equity investments from BMP and
Mediport
...
Read More
Items per page:
10
1 - 4 of 4
BioCentury
|
Aug 11, 2005
Financial News
Avontec raises EUR 14.5 million
...and DVC Deutsche Venture Capital. New investors BioMedinvest and KfW joined InnovationsKapital; UBG Goettingen-Hildesheim; and
Mediport
...
Read More
BioCentury
|
Feb 23, 2004
Emerging Company Profile
Corporate Profile
...employees: 8 Funds raised: E5.5 million ($6.4 million) Investors: DVC Deutsche Venture Capital; Innovations-Capital Goettingen;
Mediport
...
Read More
BioCentury
|
Jan 12, 2004
Emerging Company Profile
Corporate Profile
...Charité, and Medical Shool Hannover Employees: 26 Funds raised: $4.7 million Investors: Encysive Pharmaceuticals Inc.;
Mediport
...
Read More
BioCentury
|
Aug 1, 2000
Financial News
Texas Biotech funds Berlin subsidiary
...owned subsidiary, Revotar Biopharmaceuticals, raised DM10 million ($4.7 million) through equity investments from BMP and
Mediport
...
Read More
Items per page:
10
1 - 4 of 4
Previous page
Next page